Terazosin
- Product NDC
- 10544-289
- 11-digit product format
- 105440289
- Labeler code
- 10544
- Product ID
- 10544-289_0f547137-d43b-15f6-e054-00144ff8d46c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Terazosin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Blenheim Pharmacal, Inc.
- Application
- ANDA075498
- Marketing category
- ANDA
- Marketing start
- 2013-11-18
- Marketing end
- 0000-00-00
- Substance
- TERAZOSIN HYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 10544-289-30 | Terazosin | 30 in 1 BOTTLE | CAPSULE | 30 | | 1 |
| 10544-289-90 | Terazosin | 90 in 1 BOTTLE | CAPSULE | 90 | | 1 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| TERAZOSIN HYDROCHLORIDE | ACTIVE INGREDIENT | D32S14F082 | TERAZOSIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| TERAZOSIN | ACTIVE MOIETY | 8L5014XET7 | TERAZOSIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| AMMONIA | INACTIVE INGREDIENT | 5138Q19F1X | TERAZOSIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| D&C RED NO. 28 | INACTIVE INGREDIENT | 767IP0Y5NH | TERAZOSIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | TERAZOSIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | TERAZOSIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | TERAZOSIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | TERAZOSIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | TERAZOSIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| POTASSIUM HYDROXIDE | INACTIVE INGREDIENT | WZH3C48M4T | TERAZOSIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | TERAZOSIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | TERAZOSIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | TERAZOSIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | TERAZOSIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | TERAZOSIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | TERAZOSIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 10544-289 | TERAZOSIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | Legacy NDC, 2 package rows | 20150218_0f547137-d43a-15f6-e054-00144ff8d46c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 10544-289-30 | 10544028930 | 30 in 1 BOTTLE | Historical |
| 10544-289-90 | 10544028990 | 90 in 1 BOTTLE | Historical |